The U.S. government filed its brief in opposition yesterday to Janssen Pharmaceuticals and Bristol Myers Squibb Company’s (BMS) petition for writ of certiorari challenging the government’s Medicare Dr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results